Uptake Drivers for Generic and Biosimilar Medicines Group
Page last updated: 10 October 2018
The Uptake Drivers for Generic and Biosimilar Medicines Group met on 6 April 2018. Attendees included representatives from the Generic and Biosimilar Medicines Association, industry and the Department of Health.
This was the second meeting of the Uptake Drivers for Generic and Biosimilar Medicines Group.
Members discussed Biosimilar Policy including PBS data, uptake drivers and PBS listing changes. The Uptake Drivers for Generic and Biosimilar Medicines Group will continue to monitor the uptake of generic small molecule and biosimilar medicines within Australia.
